TcLand Licenses Patents to Develop RA Companion Dx | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biomarker firm TcLand Expression today said it has entered a licensing agreement with Inserm Transfert for two patents covering gene expression biomarkers that may be predictive of response to rheumatoid arthritis therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.